Study objective: To compare the safety of salmeterol xinafoate or placebo added to usual asthma care. Design: A 28-week, randomized, double-blind, placebo-controlled, observational study.

During phase 2, subjects were recruited directly by the study investigators. The Salmeterol Multicenter Asthma Research Trial (SMART) was a multicenter, randomized, double-blind, parallel-group ...

A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose ...

Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 13.89%, which has investors questioning if this is ...

After hours: 7:59:26 p.m. EST ...